Companies / Lexeo Therapeutics, Inc. / Activity
Activity — Lexeo Therapeutics, Inc.
15 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Townsend Richard Nolan CEO | Sell | Common Stock | $64.9K | -10K -2.53% | 392,483 0.48% of shares | low |
| Feb 18, 2026 | Otero Jose Manuel Executive | Sell | Common Stock | $19.3K | -3K -2.35% | 125,460 0.15% of shares | low |
| Mar 13, 2026 | Otero Jose Manuel Executive | Grant | Common Stock | $15.7K | +6K +4.73% | 131,390 0.16% of shares | low |
| Mar 13, 2026 | Townsend Richard Nolan CEO | Grant | Common Stock | $6.9K | +3K +0.67% | 395,106 0.48% of shares | low |
| Nov 18, 2025 | Otero Jose Manuel Executive | Sell | Common Stock | $6.7K | -721 -1.12% | 63,476 0.08% of shares | low |
| Feb 13, 2026 | Bhalla Narinder Pal Executive | Grant | Common Stock | $0 | +50K | 49,500 0.06% of shares | low |
| Feb 4, 2026 | Tamayo Louis Edward Executive | Grant | Common Stock | $0 | +45K +99.26% | 89,665 0.11% of shares | low |
| Feb 4, 2026 | Otero Jose Manuel Executive | Grant | Common Stock | $0 | +65K +102.40% | 128,476 0.16% of shares | low |
| Feb 4, 2026 | Townsend Richard Nolan CEO | Grant | Common Stock | $0 | +162K +67.08% | 402,656 0.49% of shares | low |
| Jun 25, 2026 | Diaz Reinaldo M Director | Grant | Stock Option (right to buy) | — | +35K | 35,000 0.04% of shares | low |
| Jun 25, 2026 | Cholmondeley Paula H Director | Grant | Stock Option (right to buy) | — | +35K | 35,000 0.04% of shares | low |
| Feb 13, 2026 | Bhalla Narinder Pal Executive | Grant | Stock Option (right to buy) | — | +297K | 297,000 0.36% of shares | low |
| Feb 4, 2026 | Tamayo Louis Edward Executive | Grant | Stock Option (right to buy) | — | +227K | 226,665 0.28% of shares | low |
| Feb 4, 2026 | Otero Jose Manuel Executive | Grant | Stock Option (right to buy) | — | +260K | 260,000 0.32% of shares | low |
| Feb 4, 2026 | Townsend Richard Nolan CEO | Grant | Stock Option (right to buy) | — | +647K | 646,665 0.79% of shares | low |